Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.34 - $6.98 $691,814 - $1.45 Million
207,130 New
207,130 $1.39 Million
Q3 2022

Nov 14, 2022

BUY
$3.01 - $5.22 $60,482 - $104,890
20,094 Added 10.53%
210,979 $730,000
Q2 2022

Aug 15, 2022

SELL
$2.25 - $9.99 $17,093 - $75,894
-7,597 Reduced 3.83%
190,885 $563,000
Q1 2022

May 11, 2022

BUY
$8.12 - $16.9 $7,372 - $15,345
908 Added 0.46%
198,482 $1.75 Million
Q4 2021

Feb 11, 2022

BUY
$15.91 - $21.88 $7,445 - $10,239
468 Added 0.24%
197,574 $3.17 Million
Q3 2021

Nov 12, 2021

BUY
$19.74 - $28.7 $434,635 - $631,916
22,018 Added 12.58%
197,106 $4.13 Million
Q2 2021

Aug 11, 2021

SELL
$20.49 - $35.63 $2.28 Million - $3.97 Million
-111,363 Reduced 38.88%
175,088 $4.7 Million
Q1 2021

May 13, 2021

BUY
$18.99 - $33.2 $1.15 Million - $2.02 Million
60,818 Added 26.95%
286,451 $9.12 Million
Q4 2020

Feb 09, 2021

BUY
$19.41 - $26.0 $221,603 - $296,842
11,417 Added 5.33%
225,633 $5.16 Million
Q3 2020

Nov 12, 2020

BUY
$24.69 - $31.6 $101,475 - $129,876
4,110 Added 1.96%
214,216 $5.4 Million
Q2 2020

Aug 12, 2020

BUY
$5.2 - $29.12 $9,396 - $52,619
1,807 Added 0.87%
210,106 $5.87 Million
Q1 2020

May 06, 2020

SELL
$4.28 - $12.11 $11,573 - $32,745
-2,704 Reduced 1.28%
208,299 $1.21 Million
Q4 2019

Feb 14, 2020

BUY
$7.95 - $12.27 $175,981 - $271,608
22,136 Added 11.72%
211,003 $2.3 Million
Q3 2019

Nov 07, 2019

SELL
$12.44 - $17.48 $142,089 - $199,656
-11,422 Reduced 5.7%
188,867 $2.41 Million
Q2 2019

Aug 12, 2019

BUY
$14.51 - $19.71 $469,833 - $638,209
32,380 Added 19.28%
200,289 $3.4 Million
Q1 2019

May 14, 2019

BUY
$11.11 - $25.6 $72,926 - $168,038
6,564 Added 4.07%
167,909 $3.02 Million
Q4 2018

Feb 11, 2019

SELL
$11.75 - $21.42 $246 - $449
-21 Reduced 0.01%
161,345 $2.05 Million
Q3 2018

Nov 09, 2018

BUY
$19.26 - $23.46 $13,713 - $16,703
712 Added 0.44%
161,366 $0
Q2 2018

Aug 06, 2018

SELL
$19.78 - $24.67 $103,706 - $129,344
-5,243 Reduced 3.16%
160,654 $3.32 Million
Q1 2018

May 15, 2018

BUY
$18.89 - $32.46 $241,338 - $414,708
12,776 Added 8.34%
165,897 $4.17 Million
Q4 2017

Feb 09, 2018

BUY
$16.19 - $20.3 $2.48 Million - $3.11 Million
153,121
153,121 $2.91 Million

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.